−£175k
1 period on recordActive15520280Private limited companyLondon
SYNX THERAPEUTICS LTD
Significant control: Sebastian Benjamin Oehm (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Synx Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Synx Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SYNX THERAPEUTICS LTD is an active private limited company (company number 15520280) incorporated on 25 February 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2025, showing net assets of −£175k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Sebastian Benjamin Oehm
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 25 February 20242 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 11 March 2027in 138 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
3
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£175k | — | — | £16k | — | — | 3 |
Current ratio105.84Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-175,017 at 28 February 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 105.84
- Incorporated two to five years agoIncorporated 25 February 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 138 days
- Next accounts duein 35 days
- Accounts period endNet liabilities £175k · micro accounts
- Incorporated
08
Similar companies in London
- THE INTERPROFESSIONAL STUDIO FOR COMPLEXITY THINKING (INTERSCT) LTDLondon · inc. Feb 2024
- NEXOKINE THERAPEUTICS LIMITEDLondon · inc. Feb 2024
- ELECTRADX UK LTDLondon · inc. Feb 2024
- SYMONDS COA CONSULTING LTDLondon · inc. Mar 2024
- AISTHESIS MEDICAL LIMITEDLondon · inc. Feb 2024
- HELENE THERAPEUTICS LIMITEDLondon · inc. Feb 2024
All companies incorporated on 25 February 2024 · in Feb 2024.
09
Reminders for SYNX THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.